Benign Prostatic Hyperplasia (BPH) is a medical condition in which the prostate gland becomes enlarged. The enlargement of the prostate gland causes urinary tract problems by blocking the flow of urine out of the body. This happens because the prostate gland surrounds the urethra, which is the tube that carries the urine from the urinary bladder to out of the body, and so, the enlargement of the gland squeezes or blocks the urethra, causing discomfort and problems while urinating.

This condition is common in geriatric men, so much so, that almost half of all men in the age bracket 51—60 years suffer from it. As per many studies and reports, up to 90% of all men over the age of 80 years all over the world suffer from benign prostatic hyperplasia. This disease is commonly treated via medications, laser-based treatment, transurethral resection of the prostate (TURP), and various other energy-based treatments such as prostate artery embolization and implants.

In the U.S., the growing prevalence of this diseases, because of the surging geriatric population in the country, is rapidly becoming a major health issue. As a result, medical researchers are conducting extensive research and development (R&D) activities for developing advanced BPH treatment procedures. Moreover, the demand for BPH medications is also rising at an explosive pace in the country. Because of these factors, the U.S. benign prostatic hyperplasia procedures market will advance rapidly in the coming years.

Out of the surgical, laser-based, and UroLift procedures, the requirement for UroLift treatment procedures is predicted to rise rapidly in the U.S. in the forthcoming years. The main factors responsible for the growing popularity of these treatment procedures are the increasing aging population, lower-costs of the procedure in comparison to the other energy-based procedures, and increasing provision of insurance coverage for this procedure by many insurance companies in the country.

Amongst the various energy-based treatment procedures, the popularity of the laser-based procedures was found to be very high in the years gone by, because of the fact that these procedures are much more effective than the traditional treatment methods and are far less likely to cause various complications such as bleeding. There are many types of laser-based treatment procedures such as those involving thulium-, holmium lasers-, and green light lasers.

Out of these, the demand for green light laser-based procedures was observed to be significantly high in the U.S. during the last few years. According to many experts, the main factor responsible for the large-scale adoption of green light laser-based procedures was the fact that these procedures allow faster recovery and cause far lesser short-term side effects in comparison to the other laser-based procedures. Moreover, these procedures significantly improve the comfort level experienced by patients while urinating.

Therefore, it can be said with complete certainty that the demand for benign prostatic hyperplasia treatment (BPH) procedures will rise enormously in the U.S. in the upcoming years, because of the growing prevalence of BPH in males and the rapid advancements and innovations being made in these procedures in the country.